Limited increase in antibody titers following mRNA SARS-CoV-2 vaccination for more than 3 years after final dose of anti-CD20 antibody-Reference-Cited by-同舟云学术

Limited increase in antibody titers following mRNA SARS-CoV-2 vaccination for more than 3 years after final dose of anti-CD20 antibody

Published:2022-01 Issue:1 Volume:115 Page:7-10
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Funakoshi Yohei^ORCID,Yakushijin Kimikazu,Ohji Goh,Hojo Wataru,Sakai Hironori,Watanabe Marika,Saeki Miki,Hirakawa Yuri,Sakai Rina,Matsumoto Sakuya,Mizutani Yu,Kitao Akihito,Miyata Yoshiharu,Saito Yasuyuki,Kawamoto Shinichiro,Yamamoto Katsuya,Ito Mitsuhiro,Nishimura Meiko,Imamura Yoshinori,Kiyota Naomi,Matsuoka Hiroshi,Mori Yasuko,Minami Hironobu

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

https://link.springer.com/content/pdf/10.1007/s12185-021-03247-y.pdf

Reference9 articles.

1. PR Tepasse W Hafezi M Lutz J Kühn C Wilms R Wiewrodt 2020 Persisting SARS-CoV-2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature Br J Haematol 190 185 188

2. P Guilpain C Bihan Le V Foulongne P Taourel N Pansu ATJ Maria 2021 Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia Ann Rheum Dis 80 e10

3. Schulze-Koops H, Krueger K, Vallbracht I, Hasseli R, Skapenko A. Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab. Ann Rheum Dis. 2020.

4. Y Herishanu I Avivi A Aharon G Shefer S Levi Y Bronstein 2021 Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia Blood 137 3165 3173

5. A Addeo PK Shah N Bordry RD Hudson B Albracht M Marco Di 2021 Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancer Cancer Cell 39 1091 8.e2

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ensitrelvir eradicates persistent SARS-CoV-2 infection in a follicular lymphoma patient treated with anti-CD20 antibodies;Journal of Infection and Chemotherapy;2024-02

2. Retrospective Case-Control Study of REGEN-COV (Casirivimab and Imdevimab) Therapy for Patients with COVID-19 and Cancer Using the United States MarketScan® Database;Oncology;2023-09-04

3. Response to mRNA SARS‐CoV‐2 vaccination evaluated by B‐cell receptor repertoire after tixagevimab/cilgavimab administration;British Journal of Haematology;2023-06-22

4. Comparative analysis of humoral responses to BNT162b2 vaccine among patients with hematologic disorders and organ transplant recipients.;Transplant Immunology;2022-12

5. First-generation oral antivirals against SARS-CoV-2;Clinical Microbiology and Infection;2022-09